Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
74°
Site search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Symbols
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Weight Loss
Recent news which mentions Weight Loss
< Previous
1
2
3
4
5
6
Next >
Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs
March 12, 2025
Tickers
NEWS
RHHBY
Tags
Benzinga
Biotech
Large Cap
From
Benzinga
Novo Nordisk's Combo Drug CagriSema Shows 16% Weight Reduction In Second Phase 3 Trial
March 11, 2025
Tickers
NEWS
NVO
Tags
Benzinga
Biotech
Stories That Matter
From
Benzinga
Weight Loss Drugs Soar While Global Obesity Rates Climb, To Hit 50% Of Adults By 2050 Says New Report
March 06, 2025
Tickers
CDC
LLY
NEWS
NVO
Tags
Ozempic
Global
Zepbound
From
Benzinga
Teladoc Health Partners With Eli Liily's LillyDirect to Expand Access to Zepbound For Weight Loss
March 06, 2025
Tickers
LLY
NEWS
NVS
TDOC
Tags
Large Cap
Trading Ideas
Stories That Matter
From
Benzinga
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
March 05, 2025
Tickers
HIMS
NEWS
NVO
Tags
Trading Ideas
Benzinga
HIMS
From
Benzinga
Novo Nordisk Boosts Wegovy Access With Lower Pricing and Home Delivery
March 05, 2025
Tickers
LLY
NVO
Tags
Market News
Health Care
Weight Loss
From
Benzinga
AbbVie Becomes Another Big Pharma To Enter Obesity Treatment Race
March 03, 2025
Tickers
ABBV
GUBRF
LLY
NEWS
Tags
Health Care
News
Weight Loss
From
Benzinga
Novo Nordisk's Ozempic And Wegovy No Longer on FDA Shortage List, Faces Lawsuit Over Decision
February 26, 2025
Tickers
LLY
NEWS
NVO
Tags
Top Stories
General
NVO
From
Benzinga
Eli Lilly Expands Zepbound Vial Options, Lowers Prices For 2.5 mg, 5 Mg Doses
February 25, 2025
Tickers
LLY
NEWS
Tags
Benzinga
LLY
Biotech
From
Benzinga
What To Expect When Eli Lilly Reports Q4 Earnings On Thursday?
February 05, 2025
Tickers
LLY
NEWS
NVO
Tags
Stories That Matter
Analyst Ratings
Guidance
From
Benzinga
Novo Nordisk Q4 Earnings: Wegovy Sales More Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026
February 05, 2025
Tickers
NEWS
NVO
Tags
General
Top Stories
Movers
From
Benzinga
Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss
February 04, 2025
Tickers
LLY
NEWS
NVO
Tags
Benzinga
LLY
Biotech
From
Benzinga
Veru Shares Tumble Despite Enobosarm's Lean Muscle Preservation Breakthrough
January 27, 2025
Tickers
NEWS
NVO
VERU
Tags
Movers
Benzinga
why it's moving
From
Benzinga
Novo Nordisk's Weekly Amycretin Delivers Up to 22% Weight Loss in Study, Stock Soars
January 24, 2025
Tickers
NEWS
NVO
Tags
Large Cap
Trading Ideas
Stories That Matter
From
Benzinga
Revolutionising Non-Surgical Fat Loss
January 13, 2025
Tags
Wirral
Body Sculpting
Cavitation Fat Removal
From
PRLog
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
Tickers
GPCR
LLY
MRK
NEWS
Tags
Trading Ideas
Analyst Ratings
Biotech
From
Benzinga
EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
December 20, 2024
Tickers
HRTS
LLY
NVO
Tags
Health Care
Weight Loss
HRTS
From
Benzinga
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
December 02, 2024
Tickers
LLY
NEWS
NVO
Tags
Benzinga
Biotech
LLY
From
Benzinga
Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs
November 26, 2024
Tickers
AMGN
LLY
NEWS
NVO
Tags
LLY
VKTX
Biotech
From
Benzinga
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
November 21, 2024
Tickers
AMGN
LLY
NVO
Tags
Market News
Mounjaro
Long Ideas
From
Benzinga
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
November 05, 2024
Tickers
ASND
NVO
Tags
Previews
Market News
ASND
From
Benzinga
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains
October 29, 2024
Tickers
LLY
Tags
Biotech
Expert Ideas
LLY
From
Benzinga
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
September 25, 2024
Tickers
LLY
Tags
KeyProj
Zepbound
Biotech
From
Benzinga
Lose Weight With Novo Nordisk Drugs, Gain Money With Stock
September 25, 2024
Tickers
NVO
Tags
Weight Loss
Ozempic
Health Care
From
Benzinga
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
September 25, 2024
Tickers
HRTS
NVO
Tags
Specialty ETFs
Health Care
Weight Loss
From
Benzinga
Novo Nordisk To Consider Ways For Patients To Affordably Access Weight Loss Drugs Ozempic, Wegovy, Says CEO
September 24, 2024
Tickers
NVO
Tags
Government
Denmark
Biotech
From
Benzinga
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
September 20, 2024
Tickers
CRBP
NEWS
NVO
Tags
NVO
Health Care
obesity
From
Benzinga
European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
September 20, 2024
Tickers
NEWS
NVO
Tags
Large Cap
Weightloss drug
Stories That Matter
From
Benzinga
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
September 11, 2024
Tickers
VKTX
Tags
Market News
Health Care
Initiation
From
Benzinga
September Volatility Returns As Labor Cools, Bets On Large Fed Rate Cut Intensify, Semiconductors Plunge: This Week In The Markets
September 06, 2024
Tickers
AAPL
EVS
F
NVDA
Tags
AAPL
Macro Economic Events
Stories That Matter
From
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.